A new publication dated August 27, 2026 features buserelin, a GnRH analogue, in the journal Animal Reproduction Science. The study, titled "Superovulation with eCG alone or combined with the GnRH analogue buserelin improves transferable embryo production in weaned sows without affecting day 6 embryo morphological, cellular, and transcriptomic parameters," was published under PubMed ID 42679714.
The title indicates the publication examines superovulation protocols using eCG alone or in combination with buserelin in weaned sows. It further references transferable embryo production and day 6 embryo morphological, cellular, and transcriptomic parameters as areas addressed in the work.
This entry reflects only the publication record as listed, including its title, journal, and date. No specific findings, data points, or conclusions beyond the title are described here. Readers interested in the full scope of the study, including methodology and results, should consult the original publication directly through the source link provided.
For additional background on buserelin, including its regulatory status and general use as a GnRH analogue, readers can consult the compound overview for further context.